Target species
Cats
Indications for use, specifying the target species
For active immunisation of cats from eight weeks of age against:
•feline calicivirosis to reduce clinical signs.
•feline viral rhinotracheitis to reduce clinical signs and viral excretion.
•feline panleucopaenia to prevent leucopenia and to reduce clinical signs.
•feline leukaemia to prevent persistent viraemia and clinical signs of the related disease.
Onset of immunity demonstrated from:
•3 weeks after the first injection of primary vaccination for the calicivirus component
•3 weeks after the primary vaccination for the panleucopenia and leukaemia components
•4 weeks after the primary vaccination for the rhinotracheitis virus component.
After the primary vaccination course, the duration of immunity lasts for one year for all components.
Following a first booster vaccination one year after the primary vaccination course, a duration of immunity of 3 years has been demonstrated for the leukaemia component.